Cumberland Pharmaceuticals (CPIX) Accounts Payables (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Accounts Payables data on file, last reported at $4.5 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables fell 67.78% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (down 67.78% YoY), and the FY2025 full-year result was $18.6 million, changed N/A from the prior year.
• Accounts Payables declined to $4.5 million in Q1 2026, from $18.6 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $18.6 million in Q4 2025 to a low of $4.5 million in Q1 2026.
• A 5-year average of $12.1 million and a median of $11.8 million in 2022 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables climbed 29.75% in 2023 and slumped 67.78% in 2026, its largest moves.
• Tracing CPIX's Accounts Payables over 5 years: stood at $10.8 million in 2022, then grew by 29.75% to $14.0 million in 2023, then decreased by 14.1% to $12.1 million in 2024, then soared by 53.99% to $18.6 million in 2025, then sank by 75.83% to $4.5 million in 2026.
• Business Quant data shows CPIX's Accounts Payables at $4.5 million in Q1 2026, $18.6 million in Q4 2025, and $13.8 million in Q3 2025.